|
|
Pharmacoepidemiology & Pharmacogenomics Resources:
Mention of companies, products or services on this Web site is for reference purposes only
and does not constitute endorsement by NCI or the US Government.
Please read our disclaimer.
|
|
|
Pharmacogenetics & Pharmacogenomics Knowledge Base (PharmGKB)
Description
PharmGKB is a publicly available Internet research tool developed by Stanford
University with funding from the National Institutes of Health (NIH) and is part of the
NIH Pharmacogenetics Research Network (PGRN), a nationwide collaborative research
consortium. Its aim is to aid researchers in understanding how genetic variation among
individuals contributes to differences in reactions to drugs.
The PharmGKB database is a central repository for genetic, genomic, molecular and
cellular phenotype data and clinical information about people who have participated in
pharmacogenomics research studies. The data includes, but is not limited to, clinical and
basic pharmacokinetic and pharmacogenomic research in the cardiovascular, pulmonary,
cancer, pathways, metabolic and transporter domains. The contributors tab contains the
links to all of the projects submitting data to the PharmGKB. The PharmGKB welcomes
submissions of primary data from all research into genes and genetic variation and their
effects on drug and disease phenotypes.
|
|